Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Purpose

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Condition

  • Colorectal Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Known or suspected colorectal adenocarcinoma (Stage I to IVA disease) - Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent. - 18 years old or older - Willing and able to provide informed consent - Willing to have additional blood samples collected during routine surveillance visits

Exclusion Criteria

  • Not willing to have additional blood samples collected - Pathology that is not consistent with colorectal adenocarcinoma

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Participants with stage I-IV colorectal cancer (CRC) This protocol will include participants with stage I-IV CRC who are scheduled to undergo or have undergone a surgical resection with curative intent.
  • Other: Observation
    No intervention

Recruiting Locations

Mercy Clinic Oncology - Fort Smith
Fort Smith, Arkansas 72903
Contact:
Billy Cater
Billy.Cater@mercy.net

MemorialCare
Fountain Valley, California 92708
Contact:
Laura Macias
562.706.2701
LMacias@memorialcare.org

The Center for Cancer and Blood Disorders
Bethesda, Maryland 20817
Contact:
Kosunique Jenkins
301-571-2016
kosunique.jenkins@tempus.com

Mercy Clinic Oncology and Hematology - Joplin
Joplin, Missouri 64804
Contact:
Cynthia Meyer
Cynthia.Meyer@mercy.net

Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center
Springfield, Missouri 65804
Contact:
Jennifer Hylton
Jennifer.Hylton@mercy.net

Washington University School of Medicine
St Louis, Missouri 63110
Contact:
Mary Pecoraro
314-273-0884
mpecoraro@wustl.edu

Mercy Clinic Oncology and Hematology - Sindelar Cancer Center
St Louis, Missouri 63128
Contact:
Jessica Black
Jessica.Black@mercy.net

Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center
St Louis, Missouri 63141
Contact:
Emily Hoven
Emily.Hoven@Mercy.Net

Nebraska Cancer Specialists
Omaha, Nebraska 68130
Contact:
Brenda Broekemeier
308-218-6324
bbroekemeier@nebraskacancer.com

Southeastern Medical Oncology Center
Goldsboro, North Carolina 27543
Contact:
Jennifer Fields
919-587-9084
jfields@cancersmoc.com

Aultman Hospital
Canton, Ohio 44710
Contact:
Kristin Shine
Kristin.Shine@aultman.com

TriHealth Cancer Institute
Cincinnati, Ohio 45220
Contact:
Wayne Thompson
513-865-5020
Wayne_Thompson@trihealth.com

Ohio State University
Columbus, Ohio 43210
Contact:
Jennifer Moon
jennifer.moon@osumc.edu

OhioHealth Research Institute
Columbus, Ohio 43214
Contact:
Kevin Miller
614-788-3886
Kevin.Miller@ohiohealth.com

Toledo Clinic Cancer Center
Toledo, Ohio 43623
Contact:
Pam Shoup
419-214-4236
pshoup@toledoclinic.com

Mercy Clinic Oncology and Hematology - Coletta
Oklahoma City, Oklahoma 73120
Contact:
Patricia Strubhar
Patricia.Strubhar@mercy.net

Cancer Care Associates of York
York, Pennsylvania 17403
Contact:
Jennifer Stough
717-741-9229
jstough@cancercareyork.com

Utah Cancer Specialists
Salt Lake City, Utah 84124
Contact:
Angela Nuttall
801-267-5606
anuttall@utahcancer.com

University of Washington / Fred Hutchinson Cancer Center
Seattle, Washington 98109
Contact:
Bentina Marin
amarin@fredhutch.org

ThedaCare Regional Cancer Center
Appleton, Wisconsin 54911
Contact:
Rachel Luedtke
920-364-3616
Rachel.Luedtke@thedacare.org

More Details

NCT ID
NCT05234177
Status
Recruiting
Sponsor
Tempus AI

Study Contact

CRC Surveillance Study
(833) 514-4187
gemini-crc@tempus.com